Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle.

@article{Haas2000MatrixMA,
  title={Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle.},
  author={Tara L. Haas and Małgorzata Milkiewicz and Sandra J. Davis and Alan Liang Zhou and Stuart Egginton and M. D. Brown and Joseph A. Madri and Olga Hudlick{\'a}},
  journal={American journal of physiology. Heart and circulatory physiology},
  year={2000},
  volume={279 4},
  pages={
          H1540-7
        }
}
Proteolysis of the capillary basement membrane is a hallmark of inflammation-mediated angiogenesis, but it is undetermined whether proteolysis plays a critical role in the process of activity-induced angiogenesis. Matrix metalloproteinases (MMPs) constitute the major class of proteases responsible for degradation of basement membrane proteins. We observed significant elevations of mRNA and protein levels of both MMP-2 and membrane type 1 (MT1)-MMP (2.9 +/- 0.7- and 1.5 +/- 0.1-fold above… 

Figures and Tables from this paper

Regulation of Matrix Metalloproteinase Activity in Ischemic Tissue by Interleukin-10: Role in Ischemia-Induced Angiogenesis

Findings in IL-10−/− mice underscore the critical role of MMP activation, in a context of increased VEGF expression, in promoting ischemia-induced angiogenesis.

The involvement of MMP-2 and MMP-9 in heart exercise-related angiogenesis

A different spatiotemporal modulation of pro-MMP-2 and pro- MMP-9 activities has been detected in the myocardium during angiogenesis related to the aerobic training, which can be useful to draw up training protocols for improving the performance of healthy and diseased human hearts.

Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis.

The data suggest that the involvement of MMPs in capillary growth is dependent on the nature of the angiogenic stimulus, and that MMP-2 regulation occurs independent of VEGF signaling.

The Matrix Metalloproteinase and Tissue Inhibitors of Metalloproteinase Balance in Physiological and Pathological Remodeling of Skeletal Muscles

It is important to define the exact pattern of MMP/TIMP expression and regulation in normal and diseased muscles in order to identify potential targets for therapeutic approaches or biomarkers for specific disease entities and therapeutic follow-up.

Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits.

It is demonstrated that TIMP-2 is expressed by both spinal motor neurons and skeletal muscle, and the tissue specificity of the nerve branching phenotype suggests the involvement of different MMPs and/or extracellular matrix molecules underlying the TIMp-2(-/-) motor phenotype.

Matrix metalloproteinases and angiogenesis

  • C. Jackson
  • Biology
    Current opinion in nephrology and hypertension
  • 2002
These multiple regulatory pathways permit fine control over cell invasion during angiogenesis and provide new, precise strategies for targeting abnormal angiogenic, through control of matrix metalloproteinase activity.

Regulation of Proteolysis in Vascular Remodeling

The structure and function of the major matrix protease families secreted by endothelial cells: the matrix metalloproteinases (MMPs) and plasminogen activator (PA)/plasmin system and the regulation of these proteases and their inhibitors in vascular cells are described.

Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle.

It is concluded that, in stimulated muscles, NO, generated by activation of neuronal NOS by muscle activity or endothelial Nos by increased blood flow and capillary shear stress, may increase capillary proliferation in the early stages of stimulation through upregulation of VEGFR-2 and VEGF.

Cyclic Strain Stimulates Early Growth Response Gene Product 1–Mediated Expression of Membrane Type 1 Matrix Metalloproteinase in Endothelium

It is suggested that cyclic strain up-regulates the Egr-1–mediated expression ofMT1-MMP in rat microvascular EC, emphasizing the importance of hemodynamic forces in the regulation of MT1- MMP in vivo.
...

References

SHOWING 1-10 OF 45 REFERENCES

Egr-1 Mediates Extracellular Matrix-driven Transcription of Membrane Type 1 Matrix Metalloproteinase in Endothelium*

Egr-1-mediated transcription of MT1-MMP is identified as a mechanism by which endothelial cells can initiate an invasive phenotype in response to an alteration in extracellular matrix environment, thus functionally associating MT1 -MMP with a growing number of proteins known to be up-regulated by EGr-1 in responseto tissue injury or mechanical stress.

Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury.

It appears that inhibiting SMC migration with MMP inhibitors is not sufficient to inhibit lesion growth, and lesion size eventually catches up to control via increased SMC replication.

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

Understanding the cellular events involved in angiogenesis and the molecular regulation of these events has enormous clinical implications and is providing novel therapeutic targets for the treatment of a variety of diseases, including cancer.

Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells*

The results suggest that MT1-MMP activation of MMP-2 occurs in endothelial cells undergoing angiogenesis, that this activation has a functional role in endothelium cell organization, and that specific matrix interactions may be critical for the increased expression of MT1 -MMP and M MP-2.

Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.

MT1-MMP and its family may play a central role in the cell surface localization and activation of progelatinase A and via this mechanism, tumor cells use exogenous progelasinase A to mediate the proteolysis associated with invasion and metastasis.

Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

It is indicated that host-derived gelatinase A plays an important role in angiogenesis and tumor progression, suggesting the usefulness of gelatin enzyme A inhibitors for anticancer chemotherapy.

Cell surface activation of progelatinase A (proMMP-2) and cell migration

The MT-MMP/TIMP-2/MMP-2 system provides localized expression of proteolysis of the extracellular matrix required for cell migration and invasion.

In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases.

The data suggest that degradation of newly synthesized collagen is an important mechanism regulating collagen accumulation and that MMPs have an integral role in collagen turnover after balloon angioplasty.

Endothelial cell stimulating angiogenesis factor.

Endothelial cell stimulating angiogenesis factor (ESAF) is a small (> 1000 Da) dialysable non-peptide molecule with potent angiogenic activity. ESAF activates the major pro-matrix metalloproteinases

Low-molecular-mass endothelial cell-stimulating angiogenic factor in relation to capillary growth induced in rat skeletal muscle by low-frequency electrical stimulation.

Chronic electrical stimulation, which is known to increase both shear stress and wall tension in capillaries and induce angiogenesis, also increased ESAF activity.